The Rise in New Drug Approvals in 2011

Pharma IQ
Posted: 08/18/2011

This year has already seen the number of new drugs approved by the United States Food and Drug Administration (FDA) match the total number approved in 2010.

A new report compiled by Burrill & Company reveals AstraZeneca's blood-thinner Brilinta, approved in July, was the 21st to be given the go ahead by the FDA in 2011, putting the total in the first seven months of this year on par with that for the entirety of 2010.

Pharma IQ
Posted: 08/18/2011